We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

84 hedge funds and large institutions have $164M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 18 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,350% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 4

260% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 5

171% more funds holding

Funds holding: 31 → 84 (+53)

139% more capital invested

Capital invested by funds: $68.7M → $164M (+$95.3M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
84
Holders Change
+53
Holders Change %
+170.97%
% of All Funds
2.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
58
Increased
18
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$17.3M
2
VAM
Visium Asset Management
New York
+$8.55M
3
MMH
Menora Mivtachim Holdings
Israel
+$8.03M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$7.25M
5
BFA
BlackRock Fund Advisors
California
+$6.34M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$10.1M
2
PCM
Pentwater Capital Management
Florida
-$5.31M
3
FAM
Fred Alger Management
New York
-$634K
4
Millennium Management
Millennium Management
New York
-$332K
5
PAM
Panagora Asset Management
Massachusetts
-$230K
Name Holding Trade Value Shares
Change 		Change in
Stake
NI
51
Numeric Investors
Massachusetts
$279K +$301K +27,200 New
Millennium Management
52
Millennium Management
New York
$276K -$332K -30,021 -53%
VKH
53
Virtu KCG Holdings
New York
$257K +$277K +25,051 New
Ohio Public Employees Retirement System (OPERS)
54
Ohio Public Employees Retirement System (OPERS)
Ohio
$198K +$214K +19,329 New
Morgan Stanley
55
Morgan Stanley
New York
$196K +$46.9K +4,243 +28%
Northern Trust
56
Northern Trust
Illinois
$190K +$205K +18,529 New
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$190K +$205K +18,535 New
Baird Financial Group
58
Baird Financial Group
Wisconsin
$154K +$166K +15,000 New
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$153K +$164K +14,880 New
NFA
60
Nationwide Fund Advisors
Ohio
$149K +$160K +14,509 New
PPCM
61
Pillar Pacific Capital Management
California
$144K – – –
AIG
62
American International Group
New York
$136K +$147K +13,255 New
BA
63
BlackRock Advisors
Delaware
$116K +$125K +11,294 New
VOYA Investment Management
64
VOYA Investment Management
Georgia
$113K +$122K +11,000 New
PIM
65
Partner Investment Management
California
$112K +$120K +10,893 New
SCM
66
Stevens Capital Management
Pennsylvania
$107K +$116K +10,483 New
AAP
67
Ardsley Advisory Partners
Connecticut
$103K -$111K -10,000 -50%
UBS Group
68
UBS Group
Switzerland
$99K +$75.1K +6,795 +238%
SO
69
STRS Ohio
Ohio
$73K +$79.6K +7,200 New
Barclays
70
Barclays
United Kingdom
$61K +$67.8K +6,133 New
Invesco
71
Invesco
Georgia
$50K +$53.6K +4,852 New
Citigroup
72
Citigroup
New York
$32K +$34.9K +3,161 New
GWM
73
Gupta Wealth Management
California
$31K – – –
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$19.3K +$20.8K +1,882 New
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$17K +$17.9K +1,623 New
1 2
3
4

FOMX Hedge Fund Activity: Q2 2015 in Review

84 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q2 2015, worth a combined $164M — up 139% from $68.7M a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new FOMX positions and 4 closed out — a net gain of 54 holders — while 18 added to existing stakes and 5 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $17.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $10.1M sold.

  • 84 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q2 2015, up from 31 in Q1 2015.
  • Funds reported $164M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q2 2015, up 139% quarter-over-quarter.
  • 58 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q2 2015 and 4 closed out, a net change of +54 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q2 2015 was Franklin Resources, an estimated $17.3M added.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q2 2015 was Jennison Associates, an estimated $10.1M sold.

Based on aggregated 13F filings for Q2 2015.